- /
- Supported exchanges
- / US
- / FTRE.NASDAQ
Fortrea Holdings Inc. (FTRE NASDAQ) stock market data APIs
Fortrea Holdings Inc. Financial Data Overview
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical services that provides development and consulting services to clinical pharmacology and clinical development spectrum. The company also offers delivery models that include full service, functional service provider, and hybrid service structures. In addition, it delivers phase I " IV clinical trial management, clinical pharmacology, and consulting services. Fortrea Holdings Inc. enters into a strategic collaboration with Emery Pharma to provide rapid lot-by-lot, 1-methyl-4-nitrosopiperazine (MNP) testing of rifampin, the preferred drug for drug-drug interaction studies, to certify impurities are below the Acceptable Intake Limit set by U.S. Food and Drug Administration guidelines. The company has a strategic collaboration with SCT Cell Manufacturing s.r.o. to streamline development, accelerate timelines and bring advanced therapies to patients faster. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Fortrea Holdings Inc. (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Fortrea Holdings Inc. data using free add-ons & libraries
Get Fortrea Holdings Inc. Fundamental Data
Fortrea Holdings Inc. Fundamental data includes:
- Net Revenue: 2 760 M
- EBITDA: 12 100 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-05
- EPS/Forecast: 0.48
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Fortrea Holdings Inc. News
New
FTRE Crosses Above Average Analyst Target
In recent trading, shares of Fortrea Holdings Inc (Symbol: FTRE) have crossed above the average analyst 12-month target price of $36.80, changing hands for $36.99/share. When a stock reaches the targ...
2 Unprofitable Stocks with Promising Prospects and 1 We Turn Down
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital ...
Mizuho Increases Fortrea (FTRE) PT to $15 Despite Signs of Peaking Healthcare Trends
Fortrea Holdings Inc. (NASDAQ:FTRE) is one of the best young stocks to buy and hold for 3 years. On January 9, Mizuho raised the firm’s price target on Fortrea to $15 from $13, while keeping a Neutr...
FTRE vs. ACAD: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Fortrea Holdings Inc. (FTRE) or Acadia Pharmaceuticals (ACAD). But which of these two compani...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.